Recombinant purified protease nexin
US5495001A · kind A · utility
17Cited by
4References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 1994 |
| Grant date | Feb 27, 1996 |
| Priority date | — |
| Expiry date | Aug 10, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
DNA segments encoding two slightly different protease nexin I forms (PN-I.alpha. and PN-I.beta.) are cloned and expressed to provide practical quantities of PN-I for diagnostic and therapeutic use. PN-I is a serine protease inhibitor useful in controlling conditions mediated by proteolytic activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.